DNA vaccine encoding heat shock protein 90 protects from murine lupus.
Autoimmunity
DNA vaccine
Heat shock proteins
Systemic lupus erythematosus
T regulatory cells
Journal
Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438
Informations de publication
Date de publication:
22 06 2020
22 06 2020
Historique:
received:
07
02
2020
accepted:
12
06
2020
entrez:
24
6
2020
pubmed:
24
6
2020
medline:
22
6
2021
Statut:
epublish
Résumé
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the presence of autoantibodies to multiple self-antigens, including heat shock proteins (HSP). Because of the increased expression of HSP90 and abnormal immune responses to it in SLE, we investigated whether an HSP90 DNA vaccine could modulate the development and clinical manifestations of SLE in lupus-prone mice. (NZB x NZW)F Vaccination with HSP90 DNA reduced lupus disease manifestations and prolonged the survival of NZB/W mice. The protective effects of the HSP90 DNA vaccine associated with the induction of tolerogenic dendritic cells (DCs) and an expansion of T regulatory cells (Tregs). The beneficial effects of DNA vaccination with HSP90 in murine SLE support the possibility of HSP90-based therapeutic modalities of intervention in SLE.
Sections du résumé
BACKGROUND
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the presence of autoantibodies to multiple self-antigens, including heat shock proteins (HSP). Because of the increased expression of HSP90 and abnormal immune responses to it in SLE, we investigated whether an HSP90 DNA vaccine could modulate the development and clinical manifestations of SLE in lupus-prone mice.
METHODS
(NZB x NZW)F
RESULTS
Vaccination with HSP90 DNA reduced lupus disease manifestations and prolonged the survival of NZB/W mice. The protective effects of the HSP90 DNA vaccine associated with the induction of tolerogenic dendritic cells (DCs) and an expansion of T regulatory cells (Tregs).
CONCLUSIONS
The beneficial effects of DNA vaccination with HSP90 in murine SLE support the possibility of HSP90-based therapeutic modalities of intervention in SLE.
Identifiants
pubmed: 32571400
doi: 10.1186/s13075-020-02246-4
pii: 10.1186/s13075-020-02246-4
pmc: PMC7310240
doi:
Substances chimiques
Autoantibodies
0
Heat-Shock Proteins
0
Vaccines, DNA
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
152Subventions
Organisme : NICHD NIH HHS
ID : R21 HD097531
Pays : United States
Organisme : NIH HHS
ID : HD097531
Pays : United States
Références
Microbiol Immunol. 2010 May;54(5):299-307
pubmed: 20536727
Springerplus. 2016 Feb 29;5:222
pubmed: 27026916
PLoS One. 2015 May 14;10(5):e0127361
pubmed: 25974040
FEBS Open Bio. 2014 Sep 16;4:796-803
pubmed: 25349783
Science. 1996 Jul 19;273(5273):352-4
pubmed: 8662521
J Immunol. 2000 Dec 1;165(11):6148-55
pubmed: 11086048
Immunity. 2003 May;18(5):605-17
pubmed: 12753738
Semin Arthritis Rheum. 2008 Dec;38(3):195-207
pubmed: 18177689
Proc Natl Acad Sci U S A. 2010 Nov 30;107(48):20768-73
pubmed: 21068375
Ann Rheum Dis. 1993 Jun;52(6):436-42
pubmed: 8323395
Autoimmun Rev. 2009 Mar;8(5):388-93
pubmed: 19121415
Annu Rev Immunol. 2003;21:685-711
pubmed: 12615891
Curr Pharm Des. 2003;9(1):83-94
pubmed: 12570678
J Autoimmun. 1999 Mar;12(2):121-9
pubmed: 10047432
Eur J Immunol. 2015 Jul;45(7):2028-41
pubmed: 25871979
Cell Mol Immunol. 2012 May;9(3):255-66
pubmed: 22543833
Free Radic Res. 2014 Feb;48(2):168-79
pubmed: 24151936
J Immunol. 2002 Sep 15;169(6):3422-8
pubmed: 12218165
Clin Exp Immunol. 1996 Mar;103(3):429-35
pubmed: 8608642
Autoimmune Dis. 2012;2012:728605
pubmed: 23091704
Annu Rev Immunol. 1990;8:401-20
pubmed: 2188668
Arthritis Rheumatol. 2020 Jun;72(6):997-1002
pubmed: 31943822
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10637-42
pubmed: 27588900
Br J Rheumatol. 1994 Oct;33(10):923-6
pubmed: 7921751
J Autoimmun. 2001 Dec;17(4):341-6
pubmed: 11771959
J Clin Invest. 1988 Jan;81(1):106-9
pubmed: 3335628
J Immunol. 2010 Jun 15;184(12):7092-9
pubmed: 20483722
FEBS Lett. 2007 Jul 31;581(19):3689-94
pubmed: 17499247